SCHEMBL7804345

SCHEMBL7804345

O=C(O)COc1cccc(C2=CCN(C(=O)c3ccco3)CC2)c1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.52
SMN1; SMN2 Q16637 5/20 0.52
POLB P06746 3/20 0.52
GLA P06280 1/20 0.48
MAPT P10636 3/20 0.47
HTT P42858 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
PKM P14618 1/20 0.45
KMT2A Q03164 3/20 0.45
CRHBP P24387 1/20 0.45
CRHR2 Q13324 1/20 0.45
TSHR P16473 2/20 0.44
PTGDR2 Q9Y5Y4 1/20 0.43
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9011260 0.84 MAPT (0.52) ALDH1A1SMN1; SMN2POLBMAPTHTT
SCHEMBL7811217 0.82 PPARG (0.48) ALDH1A1SMN1; SMN2POLBMAPTL3MBTL1
SCHEMBL7811615 0.80 HTR1A (0.48) ALDH1A1SMN1; SMN2POLBMAPTL3MBTL1
SCHEMBL7817516 0.80 L3MBTL1 (0.69) ALDH1A1SMN1; SMN2MAPTL3MBTL1KMT2A
SCHEMBL7811365 0.79 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2MAPTHTTL3MBTL1
SCHEMBL7817235 0.77 DRD3 (0.51) SMN1; SMN2POLBMAPT
SCHEMBL7813985 0.77 KMT2A (0.41) ALDH1A1POLBMAPTPKMKMT2A
SCHEMBL7811474 0.77 MAPT (0.65) ALDH1A1SMN1; SMN2POLBGLAMAPT
SCHEMBL7814284 0.74 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2POLBGLAMAPT
SCHEMBL7814086 0.73 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2POLBGLAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607536-B1 Arylamide derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed